vimarsana.com

In this white paper, Distek presents an elegant and scalable method for the onboarding of a simple, three-dimensional, microcarrier-based hMSC (Human mesenchymal stem cell) expansion bioreactor process. Results of the study showed an 11.9-fold culture expansion at 96.5% viability after a 6-day culture period.

Related Keywords

,Application Note ,Distek ,Msc ,Mesenchymal ,Stem Cells ,Stem Cell Therapies ,Bioreactor ,Stem Cell Expansion ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.